The Confederation of Ayurvedic Renaissance Keralam Ltd or CARe Keralam is in the process of identifying 20 popular formulations for scientific validation with a view to ensuring wider acceptability for ayurvedic medicines which are now marketed mostly as food supplements.
CARe Keralam, a joint venture between the Kerala government and ayurveda industry, will be supported by the National Innovation Council and the Council for Scientific and Industrial Research (CSIR) in this attempt to give international recognition to ayurvedic medicines.
CARe Keralam recently scientifically validated the anti-diabetes formulation Nishaakathakaadhi kashayam (NKK), in a first-of-its-kind attempt in the history of ayurveda, facilitating its sale abroad. The comprehensive dossier was released at a function in Delhi on Saturday.
“We have been entrusted to do this pioneering scientific study by the National Innovation Council. We are ready to take up more such studies to promote the standardisation of ayurveda products on par with modern medicines,” CARe Keralam managing director Karimpuzha Raman said in a statement announcing the initiative.
Along with CSIR and other national agencies, it is also planning a grand ayurveda summit to popularise the age-old Indian system of medicine and identify the key products for scientific validation with the support of the industry.
Spurred by the huge response to its dossier on NKK, the group is also planning to hold a clinical trial of the formulation with a minimum of 500 subjects, to establish the efficacy and safety of the product and officially declare it safe, and in accordance with global standards.
CARe Keralam was established in Koratty in Thrissur district of Kerala with the support of the Department of Ayurveda, Yoga, Naturopathy, Unani, Sidda and Homoeopathy (Ayush) of the government of India. It has conducted a comprehensive multidisciplinary study on NKK’s eight raw materials, and the ayurvedic product formulated from them, demonstrating its efficacy on rats.
